IRIS
LUGARESI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.005
NA - Nord America 8.421
AS - Asia 4.513
SA - Sud America 353
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 7
Totale 22.343
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.358
IT - Italia 2.405
CN - Cina 1.567
UA - Ucraina 1.562
SG - Singapore 1.450
IE - Irlanda 1.338
TR - Turchia 1.078
GB - Regno Unito 1.006
SE - Svezia 719
FR - Francia 657
DE - Germania 518
FI - Finlandia 351
BR - Brasile 325
RU - Federazione Russa 221
IN - India 206
NL - Olanda 71
CA - Canada 50
IR - Iran 37
HK - Hong Kong 34
VN - Vietnam 34
CZ - Repubblica Ceca 24
JP - Giappone 24
EU - Europa 21
BE - Belgio 20
PL - Polonia 20
AT - Austria 19
IL - Israele 17
ES - Italia 16
BD - Bangladesh 14
AR - Argentina 11
MX - Messico 11
CH - Svizzera 10
GR - Grecia 10
ZA - Sudafrica 10
DK - Danimarca 8
KR - Corea 8
AU - Australia 7
EC - Ecuador 6
IQ - Iraq 6
LT - Lituania 6
PK - Pakistan 6
MA - Marocco 5
MK - Macedonia 5
RS - Serbia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
HR - Croazia 3
KE - Kenya 3
KZ - Kazakistan 3
RO - Romania 3
TW - Taiwan 3
VE - Venezuela 3
LU - Lussemburgo 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 22.343
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.782
Chandler 1.482
Dublin 1.327
Singapore 981
Southend 794
Princeton 616
Izmir 599
Nanjing 462
Wilmington 348
Cambridge 302
Beijing 251
Santa Clara 217
The Dalles 214
Ashburn 212
Altamura 199
Nanchang 181
Dearborn 157
Ann Arbor 150
Woodbridge 130
Rome 120
Milan 107
Boardman 96
New York 94
Shenyang 93
Jiaxing 88
Hebei 81
Chieti 75
Kunming 74
Tianjin 69
Norwalk 64
Los Angeles 61
Houston 60
Grevenbroich 46
Hangzhou 45
Changsha 42
Bologna 41
Naples 41
Munich 40
San Mateo 39
Torino 39
Helsinki 36
Florence 35
Washington 35
Dong Ket 33
Hong Kong 33
São Paulo 31
Leawood 30
Ardabil 29
Bari 26
Orange 26
Turin 26
Augusta 25
Moscow 25
Jinan 24
London 22
Lanzhou 21
Changchun 20
Verona 20
Brno 19
Nuremberg 19
Genoa 18
Guangzhou 18
Catania 17
Palermo 17
Pisa 17
Turku 16
Brussels 15
Cedar Knolls 15
Monmouth Junction 15
Ningbo 15
Seattle 15
Toronto 15
Campobasso 14
Dallas 13
Padova 13
Pescara 13
Catanzaro 12
Genova 12
Hanover 12
Rio de Janeiro 12
Warsaw 12
Zhengzhou 12
Brooklyn 11
Falls Church 11
Auburn Hills 10
Belo Horizonte 10
Frankfurt am Main 10
San Francisco 10
Taizhou 10
Casièr 9
Parma 9
Poggio Picenze 9
Tappahannock 9
Boston 8
Montreal 8
Mumbai 8
Stockholm 8
Trieste 8
Venezia 8
Vienna 8
Totale 12.836
Salva come PNG Salva come JPEG
Nome #
La risposta simpatica cutanea: basi neurofisiologiche, valori normativi, applicazioni cliniche 1.529
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 368
Ruolo degli anticorpi anti-gangliosidi nelle neuropatie e nelle malattie del motoneurone 191
Miastenia gravis "distale" e neuronopatia sensitiva simulanti una neuropatia sensori-motoria 188
Un caso di mieloneuropatia da HTLV- I in Italia 185
Polineuropatia assonale cronica progressiva sensibile al trattamento steroideo: una neuropatia assonale primitiva o una variante della poliradicoloneuropatia cronica ingiammatoria demielinizzante? 167
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 155
IL 13 in multiple sclerosis 131
Anti-GD1a Antibodies from Acute Motor Axonal Neuropathy Patients Selectively Bind to Ranvier Nodes of Motor Nerve Fibers 126
Cleavage of cystatin C is not associated with multiple sclerosis 117
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 115
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients. 113
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 109
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 108
Studio comparativo multicentrico sulla misurazione degli anticorpi IgM ANTI-GM1 nel siero di pazienti con neuropatia motoria multifocale e sclerosi laterale amiotrofica 107
Utilità dell'ecobiometria del nervo ottico nella diagnosi e nel follow-up della neurite ottica retrobulbare 107
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 107
"Minimal" chronic inflammatory demyelinating polyneuropathy 104
Utilità della tecnica destir (RM) nella diagnosi di neurite ottica retrobulbare 103
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 103
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 102
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 102
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 101
Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier 100
Increasing age at disability milestones among MS patients in the MSBase Registry 100
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 99
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 98
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 97
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 97
Adhesion molecule expression in sural nerve of chronic inflammatory demyelinating polineuropaty 96
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 96
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 96
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 96
F response in vascular and degenerative upper motor neuron lesions 95
Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant. 94
Chronic inflammatory demyelinating polyneuropathy in diabetes 93
Transdermal scopolamine cycloplegia in juvenile diabetes 93
Neurite ottica retrobulbare: studio biometrico del nervo ottico 92
Autoimmunity and interferon beta1B 91
Binding of Anti GD1 a Antibodies in Peripheral Nerve. Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group - Chieti, March 26-27 1999 91
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 91
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 91
Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery 90
Effect of TNF intraneural injection into the rat sciatic nerve 89
Anti-ganglioside antibodies in the Guillain-Barré syndrome (GBS): a case control study 89
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 89
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 89
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 89
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 88
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 88
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei 88
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 88
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 87
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 86
May electrophysiology differentiate chronic inflammatory demyelinating polyneuropathy (CIDP) and polineuropathy with anti- SGPG antibodies? 86
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 86
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 86
Interferon beta normalizes suppressor cell function in dysimmune neuropathies. 86
Interferon beta1b: the Chieti experience 85
Chronic inflammatory demyelinating polyneuropathy in diabetes mellitus 85
Effect of rhTNF-alpha injection into rat sciatic nerve 85
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 85
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 85
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 85
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 84
Neurite ottica: relazione tra perimetria, PEV e RMN 84
Effects of IL10 on recombinant interferon-beta1b stimulated suppressor cell function in MS and controls subjects 84
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 84
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 84
Anti-glicolipid antibodies in chronic inflammatory demyelinating polyneuropathy (CIDP) 83
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 83
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? 83
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 83
Interferon beta normalizes suppressor cell function in dysimmune neuropathies 82
Caratteristiche elettrofisiologiche della polineuropatia acuta assonale motoria associata ad elevato titolo di anticorpi anti-GD1a 82
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 82
Expression of adhesion molecules in sural nerve of chronic inflammatory demyelinating polyneuropathy (CIDP) 81
TheND1 gene of complex I is a mutational hot spot for Leber’s hereditary optic neuropathy 81
Sclerosi multipla: meccanismi patogenetici alla base della demielinizzazione 81
Patterns in patients’expression of emotions and neurologists’ response. 81
rlFN-beta-1B stimulated suppressor cell function in multiple sclerosis: effects of anti-IL-10 monoclonal antibody 80
Serum soluble adhesion molecules and proinflammatory cytokines are not increased in chronic inflammatory demyelinating polyneuropathy 80
Interferone beta: effetti collaterali 80
Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis 80
Extrapyramidal syndrome and depression induced by flunarizine 80
Interferon therapy in dysimmune neuropathies 79
Aspetti immunologici delle poliradicoloneuriti croniche 78
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 78
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 78
Shared T Cell Receptor Usage of Cerebrospinal Fluid Cells in Familial Multiple Sclerosis da: X° National A.I.N.I. Congress Association Italiana Neuroimmunologia - Florence, Italy, November 15/16,1999 77
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 77
CNS involvement in chronic inflammatory polyneuropathy. An electrophysiological and MRI study 77
Protein profiling of Guillain-Barrè Syndrome cerebrospinal fluid by two dimensional electrophoresis and mass spectrometry. 77
JCV-Ab serostatus in MS patients treated with Natalizumab 77
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 77
A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients. 77
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 77
Low dose oral methotrexate (MTX) in chronic progressive (CP) multiple sclerosis (MS) 77
Demyelinating motor Guillain-Barré syndrome following Rubella 77
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis 76
Totale 11.139
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.218
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.218
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 0 0 0 0 0 0 27
2020/20211.936 317 10 312 18 154 388 19 14 176 218 183 127
2021/20221.200 13 21 19 193 62 35 42 99 94 27 198 397
2022/20234.212 376 504 192 499 416 851 290 302 488 55 129 110
2023/20241.870 152 105 109 52 84 545 465 75 24 43 37 179
2024/20253.909 342 773 737 77 87 141 117 261 396 243 572 163
Totale 22.574